203 related articles for article (PubMed ID: 24648775)
1. Reviewing the options for local estrogen treatment of vaginal atrophy.
Lindahl SH
Int J Womens Health; 2014; 6():307-12. PubMed ID: 24648775
[TBL] [Abstract][Full Text] [Related]
2. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.
Menopause; 2013 Sep; 20(9):888-902; quiz 903-4. PubMed ID: 23985562
[TBL] [Abstract][Full Text] [Related]
3. [Local estrogen therapy--clinical implications--2012 update].
Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
[TBL] [Abstract][Full Text] [Related]
4. Vulvar and Vaginal Atrophy: Physiology, Clinical Presentation, and Treatment Considerations.
Lev-Sagie A
Clin Obstet Gynecol; 2015 Sep; 58(3):476-91. PubMed ID: 26125962
[TBL] [Abstract][Full Text] [Related]
5. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
6. SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004.
Society of Obstetricians and Gynaecologists of Canada
Int J Gynaecol Obstet; 2005 Feb; 88(2):222-8. PubMed ID: 15779109
[TBL] [Abstract][Full Text] [Related]
7. Vaginal estrogens for the treatment of dyspareunia.
Krychman ML
J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
[TBL] [Abstract][Full Text] [Related]
8. The detection and management of vaginal atrophy.
Johnston SL; Farrell SA; Bouchard C; Farrell SA; Beckerson LA; Comeau M; Johnston SL; Lefebvre G; Papaioannou A;
J Obstet Gynaecol Can; 2004 May; 26(5):503-15. PubMed ID: 15151738
[TBL] [Abstract][Full Text] [Related]
9. Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.
Simon JA; Maamari RV
Climacteric; 2013 Aug; 16 Suppl 1():37-43. PubMed ID: 23848490
[TBL] [Abstract][Full Text] [Related]
10. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
Kingsberg SA; Wysocki S; Magnus L; Krychman ML
J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
[TBL] [Abstract][Full Text] [Related]
11. Barriers to effective treatment of vaginal atrophy with local estrogen therapy.
Reiter S
Int J Gen Med; 2013; 6():153-8. PubMed ID: 23525842
[TBL] [Abstract][Full Text] [Related]
12. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
Edwards D; Panay N
Climacteric; 2016 Apr; 19(2):151-61. PubMed ID: 26707589
[TBL] [Abstract][Full Text] [Related]
13. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
[TBL] [Abstract][Full Text] [Related]
14. Overcoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophy.
Chism LA
Int J Womens Health; 2012; 4():551-7. PubMed ID: 23091401
[TBL] [Abstract][Full Text] [Related]
15. Current treatment options for postmenopausal vaginal atrophy.
Naumova I; Castelo-Branco C
Int J Womens Health; 2018; 10():387-395. PubMed ID: 30104904
[TBL] [Abstract][Full Text] [Related]
16. Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen.
Simon JA
J Womens Health (Larchmt); 2011 Oct; 20(10):1453-65. PubMed ID: 21819250
[TBL] [Abstract][Full Text] [Related]
17. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy.
Derzko C; Elliott S; Lam W
Curr Oncol; 2007 Dec; 14 Suppl 1(Suppl 1):S20-40. PubMed ID: 18087605
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
Archer DF
Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
[TBL] [Abstract][Full Text] [Related]
19. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
Tan O; Bradshaw K; Carr BR
Menopause; 2012 Jan; 19(1):109-17. PubMed ID: 22011753
[TBL] [Abstract][Full Text] [Related]
20. Urogenital atrophy: prevention and treatment.
Willhite LA; O'Connell MB
Pharmacotherapy; 2001 Apr; 21(4):464-80. PubMed ID: 11310520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
